Flexion Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 33 U.S.-traded ETFs. FLXN has around 3.0M shares in the U.S. ETF market. The largest ETF holder of FLXN is the SPDR S&P Biotech ETF (XBI), with approximately 784.15K shares. Investors may also find of interest that the ETF with the largest allocation to FLXN stock is Invesco Raymond James SB-1 Equity ETF (RYJ), with a portfolio weight of 0.77%. On average, U.S. ETFs allocate 0.08% of FLXN to their portfolios.
Additionally, FLXN is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with FLXN as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.